PHARMACY & PHARMACOLOGY (PHARM) -> PHARM - Mechanical Circulatory Support Abstracts

504 - Early Experience with Elimination of Aspirin from the Antithrombotic Regimen of Patients with a HeartMate IIITM Left Ventricular Assist Device

Presentation Number
504
Speakers
Session Name
MINI ORAL 14 - MINI ORAL SESSION: Pharmacy and Pharmacology
Date
Thu, Apr 23, 2020
Time
06:15 PM - 07:15 PM
Authors

Previous ePresentation
503 - Safety of Traditionally Dosed Enoxaparin in Patients Supported with Left Ventricular Assist Devices

Next ePresentations
506 - Carfilzomib for Heart Transplant Desensitization
508 - Effect of Statin Intensity in the Prevention of Cardiac Allograft Vasculopathy
511 - Evaluation of Universal versus Preemptive Antifungal Prophylaxis in Lung Transplantation
516 - Measuring and Monitoring Equity in Access to Deceased Donor Lung Transplants among Waitlisted Candidates
519 - Initial Successful Clinical Transplantation Using Negative Pressure Ventilation Ex-Situ Lung Perfusion with Extended Criteria Donor Lungs
521 - Low Lung Allocation Score Predicts Poor Waitlist Outcomes for Patients on Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation
522 - "Awake" Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant
535 - Polyfunctional CD8+ T Cells are Associated with Biopsy Proven Acute Cellular Rejection in Pediatric Heart Transplant Patients
539 - Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients - 3-year Results from the HITTS Randomized Controlled Trial
541 - Prevalence and Clinical Predictors of Aspirin Resistance in Heart Transplant Recipients